Irene Cuppari: Whole Blood and Component Therapy in Traumatic Hemorrhage
Irene Cuppari, Director of Transfusion Medicine Service ASST Ovest Milanese, shared Blood Transfusion Journal‘s post on LinkedIn about a recent article she and her colleagues co-authored, published in BT, adding:
“I am pleased to share this Commentary recently published in Blood Transfusion, focused on the use of whole blood in the treatment of traumatic hemorrhage in the prehospital setting.
The recent SWiFT and TOWAR trials represent an important milestone, as they introduce phase 3 randomized evidence in a field that has so far been supported mainly by observational data and physiological rationale.
The message that emerges is clear, though not definitive: whole blood did not demonstrate superiority over component therapy in the prehospital strategies evaluated, but this should not be interpreted as evidence of equivalence or non-inferiority.
A crucial methodological and organizational debate therefore remains open: every transfusion strategy should be assessed not only in terms of clinical effectiveness, but also with regard to sustainability, appropriateness, accessibility, and impact on transfusion services.
Many thanks to my co-authors Daniele Prati, Luca Barcella, and Chiara Novelli for this collaborative work.”
Blood Transfusion Journal shared a post on LinkedIn:
“New Publication Alert
We’ve just published a new article: ‘Prehospital whole blood after SWiFT and TOWAR: not superior, not settled’, focusing on Transfusion Medicine.”
Title: Prehospital whole blood after SWiFT and TOWAR: not superior, not settled
Authors: Daniele Prati, Luca Barcella, Chiara Novelli, Irene Cuppari
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 08:28Jean Nakhle: Uncovering How Excess Cysteine Drives Cell Death
-
Sep 16, 2026, 08:20Heghine Khachatryan: Arterial and Venous Thrombosis May Require Different Approaches in Neonates
-
Sep 16, 2026, 07:57Tammuella Chrisentery-Singleton: Standing on the Shoulders of Giants in Hemophilia Care
-
Sep 16, 2026, 07:33Jakob Werner Hansen: Nordic VEX AZA Trial Reaches an Important Milestone
-
Sep 16, 2026, 06:54Jonathan Furniss: The Platelet Response That Helps Drive Tissue Repair
-
Sep 16, 2026, 05:25Paul Armstrong: Honoured to Take the Lead at The Platelet Society
-
Sep 16, 2026, 05:05Alejandro González Veliz: Why Heart Attacks in Women Can Be More Complex Than a Simple Blockage
-
Sep 16, 2026, 04:58Thomas Dayspring – Your LDL Is Normal – But Are You Really Safe?
-
Sep 16, 2026, 04:50Seema Dawood: Why Some Red Cells Break While Others Survive?